Pulmuone Corporate Stock

Equities

A017810

KR7017810003

Food Processing

End-of-day quote Korea S.E. 18:00:00 2024-07-16 EDT 5-day change 1st Jan Change
14,810 KRW +1.09% Intraday chart for Pulmuone Corporate -0.74% +41.18%

Financials

Sales 2024 * 3,143B 2.28B 3.12B Sales 2025 * 3,310B 2.4B 3.28B Capitalization 545B 395M 540M
Net income 2024 * 44B 31.9M 43.65M Net income 2025 * 64B 46.4M 63.49M EV / Sales 2024 * 0.46 x
Net Debt 2024 * 909B 659M 902M Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.16 x
P/E ratio 2024 *
12.8 x
P/E ratio 2025 *
8.81 x
Employees 487
Yield 2024 *
0.69%
Yield 2025 *
-
Free-Float 23.65%
More Fundamentals * Assessed data
Dynamic Chart
Pulmuone Corporate Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Korean Food Companies Boost R&D as Ramyun, Dumplings Gain Popularity MT
Pulmuone Corporate Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Pulmuone Corporate Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pulmuone Corporate announced that it has received KRW 100 billion in funding from IBK-Kiwoomp Business Recorganizaion Private Equity Fund Co., Ltd, Kiwoom Investment Co., Ltd., Lohas Private Equity Fund Co., Ltd CI
Pulmuone Corporate announced that it expects to receive KRW 100 billion in funding from IBK-Kiwoomp Business Recorganizaion Private Equity Fund Co., Ltd, Kiwoom Investment Co., Ltd., Lohas Private Equity Fund Co., Ltd CI
Pulmuone Corporate Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Pulmuone Corporate Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pulmuone Corporate Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pulmuone Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Pulmuone Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pulmuone Raises Tofu Production Capacity in China with New Facility MT
Pulmuone Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Pulmuone Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Thai Union Public : Lab-grown fish fingers anyone? Birds Eye owner explores cell-cultured seafood RE
More news
1 day+1.09%
1 week-0.74%
Current month-6.86%
1 month-15.90%
3 months+30.95%
6 months+45.48%
Current year+41.18%
More quotes
1 week
14 350.00
Extreme 14350
15 330.00
1 month
13 900.00
Extreme 13900
17 900.00
Current year
9 960.00
Extreme 9960
18 410.00
1 year
9 330.00
Extreme 9330
18 410.00
3 years
9 330.00
Extreme 9330
20 050.00
5 years
7 120.00
Extreme 7120
25 000.00
10 years
7 120.00
Extreme 7120
26 900.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 -
Founder 72 -
Director of Finance/CFO 57 -
Members of the board TitleAgeSince
Founder 72 -
Chief Executive Officer 67 -
Director/Board Member 63 -
More insiders
Date Price Change Volume
24-07-16 14,810 +1.09% 189 711
24-07-16 14,650 -2.01% 117,497
24-07-15 14,950 +2.89% 191,086
24-07-12 14,530 -1.69% 201,450
24-07-11 14,780 +0.48% 425,885

End-of-day quote Korea S.E., July 16, 2024

More quotes
PULMUONE, formerly Pulmuone Holdings Co., Ltd. is a Korea-based holding company engaged in the management of its subsidiaries. Through its subsidiaries, the Company is mainly engaged in the food manufacturing and food material distribution businesses. The Company’s subsidiaries include Pulmuone Foods Co., Ltd., which is engaged in the production of tofu, bean sprouts, eggs and noodles; Exofresh Logistics Co., Ltd., which is mainly engaged in the provision of chilled logistic business; ECMD. CO., LTD., which is engaged in the food service business; FOODMERCE, which is engaged in the distribution of food materials, and Pulmuone Health&Living CO.LTD., which is mainly engaged in the manufacture of healthcare foods.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14,810 KRW
Average target price
17,500 KRW
Spread / Average Target
+18.16%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A017810 Stock